MSRV Retrovirus, phase 2

Fred1208 · Post by **Fred1208** » Mon Oct 19, 2020 8:40 am

New videos !!

Don't forget to subscribe !!

Fred1208 · Post by **Fred1208** » Mon Oct 19, 2020 8:44 am

https://www.youtube.com/channel/UCODwH_ ... 0pA/videos

Fred1208 · Post by **Fred1208** » Thu Jan 21, 2021 1:14 am

Stay tuned !!
The new revolution is coming regarding yhe understanding of auto-immune deseases !!

For the first time, MS process could be STOPPED.

http://www.geneuro.com/data/documents/2 ... ion-MP.pdf

Fred1208 · Post by **Fred1208** » Fri Apr 16, 2021 7:11 am

Breaking news !!

http://www.geneuro.com/data/news/GeNeur ... 5-2021.pdf

Fred1208 · Post by **Fred1208** » Sat Apr 17, 2021 12:43 am

Genuero Presentation: Defeating neurodegeneration through HERVs
April 2021

http://www.geneuro.com/data/documents/2 ... tation.pdf

Fred1208 · Post by **Fred1208** » Sun Apr 18, 2021 12:09 pm

Tommrrow 6 PM swiss time

webinar, should be in english, subscriibe here :

https://register.gotowebinar.com/regist ... 5759504651

Post by **NHE** » Wed Jul 21, 2021 4:30 am

Here's an interesting write-up on endogenous retroviruses.

https://encyclopedia.thefreedictionary. ... retrovirus

TinaMeyer · Post by **TinaMeyer** » Wed Sep 22, 2021 9:00 am

Hello, here is an update concerning the extension study of the Protect-MS study with temelimab, dd 09/21/2021. This extension study allows the patients, who already have had 12 infusions, to continue the treatment with temelimab. The results of the Protect-MS study are still expected Q1 2022.

"GeNeuro announces that a first patient having finished the ProTEct-MS study at the Karolinska Institutet’s Academic Specialist Center has entered the study extension...."

Please read the full statement on the link below :

http://www.geneuro.com/en/technologies/rationale

TinaMeyer · Post by **TinaMeyer** » Wed Sep 22, 2021 9:02 am

Sorry, that's the wrong link. The good one is:

http://www.geneuro.com/data/news/GeNeur ... nt-ENG.pdf

frodo · Post by **frodo** » Mon Jan 24, 2022 4:34 am

First patient has just finished his study

https://www.businesswire.com/news/home/ ... -Extension

Fred3582 · Post by **Fred3582** » Sat Feb 19, 2022 4:00 am

Hello, the PRoTEct-MS study with temelimab is completed and the top-line results to be announced in march 2022

:

https://www.businesswire.com/news/home/ ... er-31-2021

Fred3582 · Post by **Fred3582** » Sun Mar 20, 2022 11:27 pm

Hello, good news

,

The results of the phase 2 trial with temelimab announced today:

"ProTEct-MS Phase 2 Trial Confirms Safety of Higher Doses of Temelimab and Synergistic Potential to Address Neurodegeneration on Top of Anti-inflammatory Treatment in Multiple Sclerosis..."

More here:

http://www.geneuro.com/data/news/GeNeur ... 1-2022.pdf

Fred3582 · Post by **Fred3582** » Tue Mar 22, 2022 11:03 am

Hello,

Here's a link to the presentation of these top-line results:

http://www.geneuro.ch/data/documents/GN ... 22-ENG.pdf

Fred3582 · Post by **Fred3582** » Thu Mar 24, 2022 2:00 pm

Hello,

Watch the comments of these results hereby, if you are interested

This Is MS Multiple Sclerosis Knowledge & Support Community

MSRV Retrovirus, phase 2

Re: MSRV Retrovirus, phase 2

Re: MSRV Retrovirus, phase 2

Re: MSRV Retrovirus, phase 2

Re: MSRV Retrovirus, phase 2

Re: MSRV Retrovirus, phase 2

Re: MSRV Retrovirus, phase 2

Re: MSRV Retrovirus, phase 2

Re: MSRV Retrovirus, phase 2

Re: MSRV Retrovirus, phase 2

Re: MSRV Retrovirus, phase 2

Re: MSRV Retrovirus, phase 2

Re: MSRV Retrovirus, phase 2/RESULTS

Re: MSRV Retrovirus, phase 2

Re: MSRV Retrovirus, phase 2